Blog

Where we share more information on diabetes, obesity, and other metabolic diseases.

MelliCell completes first stage of research collaboration with Novo Nordisk

Partnership validates the use of new technology in drug discovery process and furthers the possibility of more effective drug development...

Shining a light on PCOS

"I was diagnosed with PCOS in my early 20’s. It has destroyed my Navy career and subjected me to doctors who didn’t want to research,...

MelliCell to Join the Obesity Action Coalition’s Chairman's Council

Newton, Mass. — Sep 7, 2021 — MelliCell, a biotechnology company dedicated to reversing obesity and type 2 diabetes by targeting fat...

Dr. Ben Pope on Diabetes Research, Insulin Resistance, and Finding a Cure

“There are actually no drugs on the market that target the fat cells for weight loss. Even though our fat is where all our excess weight...

MelliCell Appoints Dr. Todd Zion to Advisory Board

MelliCell, a startup dedicated to reversing obesity and type 2 diabetes by targeting fat cells, has announced today the close of its...

Building Biomimetic Potency Tests for Islet Transplantation

Dr. Aaron L. Glieberman and Dr. Benjamin D. Pope were featured in the following article: https://diabetes.diabetesjournals.org/content/70...

41 views

In the News...

Dr. Ben Pope and Dr. Aaron Glieberman were quoted in the following article: https://news.harvard.edu/gazette/story/2019/08/islet-on-a-chi...

uFluidix highlights the work of Dr. Ben Pope

uFluidix highlighted one of the technologies invented by our CSO that enables adipocyte hypertrophy in vitro. Follow the link below to...

Life Extension Advocacy Foundation

Life Extension Advocacy Foundation / Lifespan.io reviewed one of the technologies our CSO invented that enables adipocyte hypertrophy in...

Blog: Blog2